Landos Biopharma Inc
Landos Biopharma Inc logo
LABP

Landos Biopharma Inc (LABP)

$0.730.29%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.695
Day's Range
$0.7532
$0.5501
52-Week Range
$16.17
1 month return6.95%
3 month return49.58%
1 year return93.17%
5 year return94.03%

Company Information

Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways. Landos Biopharma’s core expertise is in the development of therapeutic candidates targeting novel pathways at the interface of immunity and metabolism. Lead asset BT-11 is a novel, oral, gut-restricted small molecule therapeutic candidate for the treatment of ulcerative colitis and Crohn’s disease that targets the LANCL2 pathway. NX-13 is a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway. Additional candidates are in development for the treatment of lupus nephritis, rheumatoid arthritis, multiple sclerosis, and diabetes.
OrganizationLandos Biopharma Inc
CEO

Analyst Recommendation

based on 13 analysts ratings

Buy
69%
Buy
30%
Hold
0%
Sell

Based on 13 Wall street analysts offering stock ratings for Landos Biopharma Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 872.22%

Current

$0.72

Target

$7.0

Recommendation Trend

Based on 13 analyst

Current1M Ago3M Ago
Buy
9
9
9
Hold
4
4
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
42.7M
Book Value
1.9
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-1.02
Wall Street Target Price
18.82

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
2.37
Price/Book (mrq)
0.55
Enterprise Value
-48612366
Enterprise Value/Revenue
0.67
Enterprise Value/Ebitda
1.26

Technicals

50 Day MA
1.6
200 Day MA
7.98

Institutional Holdings

Perceptive Advisors LLC

36.94%

RTW INVESTMENTS, LLC

10.62%

OUP Management Co., LLC

4.54%

BlackRock Inc

1.17%

Renaissance Technologies Corp

0.85%

JPMorgan Chase & Co

0.73%

Discover more

Frequently Asked Questions

What is Landos Biopharma Inc share price today?

Can Indians buy Landos Biopharma Inc shares?

How can I buy Landos Biopharma Inc shares from India?

Can Fractional shares of Landos Biopharma Inc be purchased?

What are the documents required to start investing in Landos Biopharma Inc stocks?

What are today’s High and Low prices of Landos Biopharma Inc?

What are today’s traded volumes of Landos Biopharma Inc?

What is today’s market capitalisation of Landos Biopharma Inc?

What is the 52 Week High and Low Range of Landos Biopharma Inc?

How much percentage Landos Biopharma Inc is down from its 52 Week High?

How much percentage Landos Biopharma Inc is up from its 52 Week low?

What are the historical returns of Landos Biopharma Inc?

Who is the Chief Executive Officer (CEO) of Landos Biopharma Inc?